Delivery Order SPE2DB22D3010-SPE2DB25FP3DQ
- Not listed
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order issued under the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The order represents a child contract utilizing the broader SPE2DX vehicle, valued at approximately $1 billion and running through December 2026, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the company's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $1,635.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical...
- The Defense Logistics Agency awarded a $2,062.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive set-aside delivery order under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device...
- The Defense Logistics Agency awarded a $9,922.90 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment of medical supply needs through the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and is scheduled for completion by August 8, 2025. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $6,788.95 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 7, 2025, with a ceiling value of $1,031.20. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle, is set to be completed by August 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. No set-aside designation was...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3DQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,474.88 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a federal medical supply provider, particularly within DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle supplying a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, vaccines, and medical devices. The Dexcom G7 sensors represent a critical continuous glucose monitoring device for diabetes management, aligning with the broader scope of specialized medical supplies the contractor provides to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/8/25 |